Search
for
Sort by
Research 151–180 of 1000+
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Role of Dutasteride in the Treatment of Androgenetic Alopecia
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Finasteride inhibits epinephrine synthesis in humans: implication for sexual dysfunction
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Practical Geriatrics: Men's Sexual Health After Midlife
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- PCPT Results Could Affect Trial on Testosterone Replacement
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Why Odds Ratios Can Be Tricky Statistics
- Endocrinology
- A review on Hair Loss & Damage
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model.
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat